CAMBRIDGE NUTRITIONAL SCIENCES PLC — Director's Dealing 2014

Nov 28, 2014

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3372Y

Omega Diagnostics Group PLC

28 November 2014

The following amendment has been made to the 'Director's Dealing' announcement released on 28 November 2014 at 10:35 under RNS No 3090Y.

Mr. Shepherd's shareholding increased to 2,708,180, his percentage interest remains at 2.5 per cent.

All other details remain unchanged.

The full amended text is shown below.

OMEGA DIAGNOSTICS GROUP PLC

("Omega" or the "Company" or the "Group")

Director's Dealing

Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that Andrew Shepherd, Chief Executive Officer of the Company, today purchased 30,974 ordinary shares in the Company at 17p per share through his SIPP.

Following this transaction, Mr. Shepherd's total beneficial holding has increased to 2,708,180 ordinary shares representing 2.5 per cent. of the issued ordinary share capital of the Company.

Contacts: 

Omega Diagnostics Group PLC	Tel: 01259 763 030 or www.omegadiagnostics.com
Andrew Shepherd, Chief Executive
Kieron Harbinson, Group Finance Director    Jag Grewal, Group Sales and Marketing Director
finnCap Ltd	Tel: 020 7220 0500
Geoff Nash/Christopher Raggett (Corporate Finance) Mia Gardner (Corporate Broking)
Walbrook PR Limited	Tel: 020 7933 8780 or [email protected]
Paul McManus	Mob: 07980 541 893
Lianne Cawthorne	Mob: 07584 391 303

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSBPBTTMBATBBI